PRESS RELEASE published on 11/04/2024 at 18:00, 1 year 3 months ago BIOSYNEX SA: DECLARATION DU NOMBRE D’ACTIONS ET DES DROITS DE VOTE AU 31 OCTOBRE 2024 Déclaration du nombre d'actions et des droits de vote de BIOSYNEX SA au 31 octobre 2024. Publication du capital social et du total de droits nets. Informations réglementaires. Acquisition internationale. Chiffre d'affaires 93 M€ en 2023 Chiffre D'affaires Déclaration Capital Social BIOSYNEX SA Diagnostic De Santé
BRIEF published on 10/23/2024 at 18:05, 1 year 3 months ago Chembio Diagnostics obtient une subvention pour un nouveau test de syphilis BIOSYNEX Chembio Diagnostics Syphilis Congénitale Diagnostic Rapide Subvention Fondation Gates
BRIEF published on 10/23/2024 at 18:05, 1 year 3 months ago Chembio Diagnostics wins grant for new syphilis test BIOSYNEX Chembio Diagnostics Congenital Syphilis Rapid Diagnosis Gates Foundation Grant
PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 3 months ago BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC, FILIALE DE BIOSYNEX, REÇOIT UNE SUBVENTION POUR LE DEVELOPPEMENT D'UN TEST DPP POUR LA SYPHILIS CONGENITALE BIOSYNEX SA: Chembio Diagnostics Inc, filiale de BIOSYNEX, reçoit une subvention pour le développement d'un test DPP pour la syphilis congénitale. La Bill & Melinda Gates Foundation finance un test rapide au chevet du patient Subvention BIOSYNEX SA Syphilis Congénitale Chembio Diagnostics Inc Test DPP
PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 3 months ago BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY Chembio Diagnostics Inc., a subsidiary of BIOSYNEX, receives a grant to develop a rapid point-of-care diagnostic test for congenital syphilis supported by the Bill & Melinda Gates Foundation Grant BIOSYNEX Congenital Syphilis Chembio Diagnostics Inc. Bill & Melinda Gates Foundation
BRIEF published on 10/17/2024 at 18:05, 1 year 3 months ago BIOSYNEX SA : Résultats Semestriels 2024 et Réaménagement de la Dette Résultats Semestriels Croissance Du Chiffre D'affaires Réaménagement De La Dette Rationalisation Des Coûts Expansions Américaines
BRIEF published on 10/17/2024 at 18:05, 1 year 3 months ago BIOSYNEX SA: 2024 Half-Year Results and Debt Restructuring Revenue Growth Half-year Results Debt Restructuring Cost Rationalization American Expansions
PRESS RELEASE published on 10/17/2024 at 18:00, 1 year 3 months ago BIOSYNEX SA: RESULTATS SEMESTRIELS 2024 - FINALISATION DU PLAN DE RATIONALISATION DES COUTS ET DE REAMENAGEMENT DE LA DETTE SUR LES PROCHAINS MOIS BIOSYNEX SA annonce des résultats semestriels 2024 avec un chiffre d'affaires en forte hausse et des mesures de réduction des coûts. Discussions en cours sur le réaménagement de la dette Croissance Dette Coûts BIOSYNEX SA Résultats Semestriels 2024
BRIEF published on 07/18/2024 at 18:05, 1 year 6 months ago BIOSYNEX : Chiffre d'affaires du premier semestre 2024 en hausse de 26% Chiffre D'affaires Croissance Acquisitions Exportation Filiales Américaines
BRIEF published on 07/18/2024 at 18:05, 1 year 6 months ago BIOSYNEX: Revenue for the first half of 2024 up 26% Acquisitions Growth Turnover Export American Subsidiaries
Published on 02/06/2026 at 15:30, 5 hours 4 minutes ago Vulcan Minerals Inc. - Drilling Program Update for the Carbonear Zinc-Lead SEDEX project in Newfoundland
Published on 02/06/2026 at 13:30, 7 hours 4 minutes ago Redwood AI Corp. (formerly Marshall Technologies Corp.) Announces Closing of IPO and Listing of Shares on the Canadian Securities Exchange
Published on 02/06/2026 at 13:30, 7 hours 4 minutes ago Canex Metals Acquires 51.93% of Gold Basin and Seeks a Court-Appointed Annual General Meeting of Gold Basin Shareholders
Published on 02/06/2026 at 13:00, 7 hours 34 minutes ago Revolve Announces US$40 Million Strategic Financing With Callaway Capital
Published on 02/06/2026 at 08:00, 12 hours 34 minutes ago Caledonia Mining Corporation Plc Non-Executive Director Shareholding Notification
Published on 02/06/2026 at 19:25, 1 hour 8 minutes ago Funding Circle Holdings plc: POS-Transaction in Own Shares
Published on 02/06/2026 at 17:52, 2 hours 42 minutes ago EQS-Adhoc: Avemio AG: Preparation of the filing for insolvency proceedings by Teltec AG, a subsidiary of Avemio AG, and potential effects on the going-concern assessment of Avemio AG
Published on 02/06/2026 at 17:40, 2 hours 54 minutes ago Carvolix : Nombre d’actions composant le capital social et nombre total de droits de vote au 31.01.26.
Published on 02/06/2026 at 16:55, 3 hours 39 minutes ago GAC MPV Serves as Official Reception Fleet for APEC China 2026, Demonstrating the Strength of Chinese Manufacturing
Published on 02/06/2026 at 15:25, 5 hours 9 minutes ago CES 2026 Innovation Award Honoree iGarden M1 Pro Max Launches as World's First Bionic Dual-Vision Pool Cleaner
Published on 02/06/2026 at 18:22, 2 hours 12 minutes ago Déclaration du nombre d’actions et droits de vote au 31 janvier 2026
Published on 02/06/2026 at 18:22, 2 hours 12 minutes ago Disclosure of Share Capital and Voting Rights as of January 31, 2026
Published on 02/06/2026 at 16:01, 4 hours 33 minutes ago Notice of exercise of early redemption option of the subordinated note ISIN : FR0010093328
Published on 02/06/2026 at 16:01, 4 hours 33 minutes ago Exercice de l’option de remboursement de l'instrument subordonné FR0010093328
Published on 02/06/2026 at 07:54, 12 hours 40 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 janvier 2026